Ixtlan Bioscience
Ixtlan Bioscience focused on developing psilocybin-based treatment for Alzheimer's Disease and Brain Pathologies.
Ixtlan Bioscience is a business in biotechnology, health care based in Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA), founded in 2020.
Its activity falls under biotechnology, health care; the profile below is assembled from public directory data.
Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) is where the company is located.
Directory data places it at the Private company stage.
Recorded headcount: c_00001_00010 employees.
| Sector | Biotechnology, Health Care |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA) |
| Founded | 2020 |
| Employees | c_00001_00010 |
| Stage | Private company |
Website: www.ixtlanbioscience.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account